The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(4-Methyl-5-(4-(piperazin-1-yl)phenyl)pyridin-3-yl)isoindolin-1-one ID: ALA4575999
PubChem CID: 155564334
Max Phase: Preclinical
Molecular Formula: C24H24N4O
Molecular Weight: 384.48
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1c(-c2ccc(N3CCNCC3)cc2)cncc1-c1ccc2c(c1)CNC2=O
Standard InChI: InChI=1S/C24H24N4O/c1-16-22(17-2-5-20(6-3-17)28-10-8-25-9-11-28)14-26-15-23(16)18-4-7-21-19(12-18)13-27-24(21)29/h2-7,12,14-15,25H,8-11,13H2,1H3,(H,27,29)
Standard InChI Key: ZCLWKSOLVKDHKE-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
28.0266 -18.3249 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.0254 -19.1485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7335 -19.5575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4473 -19.1480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4445 -18.3213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7317 -17.9119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7393 -20.3766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0257 -20.7886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0252 -21.6091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7333 -22.0187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4476 -21.6059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4447 -20.7867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7420 -22.8374 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.0288 -23.2496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0277 -24.0674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7382 -24.4791 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.4472 -24.0709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4500 -23.2470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1598 -19.5555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1517 -17.9072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8654 -18.3189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8542 -16.6763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1473 -17.0892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5725 -17.0820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5755 -17.9021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3563 -18.1528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8360 -17.4876 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.3516 -16.8259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6013 -16.0478 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
3 7 1 0
13 14 1 0
13 18 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
10 13 1 0
4 19 1 0
20 21 2 0
21 25 1 0
24 22 1 0
22 23 2 0
23 20 1 0
5 20 1 0
24 25 2 0
25 26 1 0
26 27 1 0
27 28 1 0
28 24 1 0
28 29 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 384.48Molecular Weight (Monoisotopic): 384.1950AlogP: 3.38#Rotatable Bonds: 3Polar Surface Area: 57.26Molecular Species: BASEHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.80CX Basic pKa: 8.88CX LogP: 2.96CX LogD: 1.48Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.73Np Likeness Score: -0.32
References 1. Ensan D, Smil D, Zepeda-Velázquez CA, Panagopoulos D, Wong JF, Williams EP, Adamson R, Bullock AN, Kiyota T, Aman A, Roberts OG, Edwards AM, O'Meara JA, Isaac MB, Al-Awar R.. (2020) Targeting ALK2: An Open Science Approach to Developing Therapeutics for the Treatment of Diffuse Intrinsic Pontine Glioma., 63 (9): [PMID:32369358 ] [10.1021/acs.jmedchem.0c00395 ]